Interventional treatment system for peripheral vascular diseases including complex blood vessel lesion management.
Manufactured by
BrosMed Medical Co., Ltd.
China
BrosMed Medical Co., Ltd., established in 2012, is a multinational medical device company specializing in high-performance endovascular interventional devices. Headquartered in Dongguan with subsidiaries in China, Netherlands, Singapore, and India. The company holds over 400 product registration certificates across 80+ countries, covering cardiovascular intervention, peripheral vascular intervention, vascular access, neurointervention, and interventional accessories.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
APT Medical
China · 1 relevant product
Princeton Medical Scientific Co.,Ltd
China · 1 relevant product
Shanghai HeartCare Medical Technology Co., Ltd.
China · 2 relevant products
53 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 81 closest product alternatives
APT Medical · China
Endovascular intervention system for lower limb vascular disease treatment providing comprehensive solution for peripheral arterial occlusive disease.
Princeton Medical Scientific Co.,Ltd · China
A range of devices designed for peripheral vascular intervention procedures. These products are used in the treatment of peripheral artery disease and related vascular conditions.
Shanghai HeartCare Medical Technology Co., Ltd. · China
Interventional system for acute ischemic stroke management. Enables mechanical thrombectomy and cerebral revascularization in patients unsuitable for thrombolytic therapy.
78 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products